HOME >> BIOLOGY >> NEWS
Discovery of gene will likely lead to new treatments for inflammatory diseases, cancer

(Boston) -- In a paper featured today in Proceedings of the National Academy of Science (PNAS), researchers from Boston University School of Dental Medicine report the discovery of a new gene, STAT6(B), that helps regulate production of the potentially deadly tumor necrosis factor alpha (TNF-alpha) cytokine. TNF-alpha is involved in inflammatory disorders such as Crohn's disease, rheumatoid arthritis, and irritable bowel syndrome. The paper is the first by a dental school researcher to be chosen as a featured article in PNAS.

The new gene also regulates vascular endothelial growth factor (VEGF), which is responsible for new blood vessels. Blocking excess amounts of VEGF has already led to the cancer therapeutic Avastin; STAT6(B) works through a different mechanism and thus will offer new opportunities for treating cancer. The researchers are publishing this finding in a separate paper.

STAT6(B), which is similar to the previously known STAT6 gene, works closely with a gene known as LITAF, discovered by the same Boston University researchers in 1999. The STAT6(B) and LITAF proteins (which are coded for by their respective genes) bind to form a complex that moves into the cell's nucleus to regulate the transcription of cytokines. The recent Boston University findings will offer new ways to regulate TNF-alpha, whose overexpression causes inflammatory and immunological problems.

Drugs regulating TNF-alpha such as Remicade, Embrel, and Humira are a multibillion dollar market. "Because STAT6(B) and LITAF affect TNF-alpha through a different pathway, we expect to develop more efficient therapeutics to help people with rheumatoid arthritis, Crohn's disease, and inflammatory bowel syndrome," says Boston University School of Dental Medicine Professor Salomon Amar, the leading author of the paper.

The Boston University researchers are now working on animal models to control LITAF and thus TNF-alpha overproduction in inflammatory syndromes. <
'"/>

Contact: Mari Megias
megias@bu.edu
617-638-5147
Boston University
28-Mar-2005


Page: 1 2

Related biology news :

1. Discovery of new protein could provide new understanding of male fertility
2. Discovery in plant virus may help prevent HIV and similar viruses
3. Discovery could help bring down price of DNA sequencing
4. Discovery in orange cauliflower may lead to more nutritious crops
5. Discovery of new family of pseudo-metallic chemicals
6. Discovery in plants suggests entirely new approach to treating human cancers
7. Discovery of master switch for the communication process between chloroplast and nuclei of plants
8. Discovery of new cave millipedes casts light on Arizona cave ecology
9. Discovery of chemical profiles for infectious diarrhea
10. Discovery could lead to better control of hemorrhagic fever viruses
11. Honey bee researcher wins National Research Initiative Discovery Award

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/6/2019)... ... June 05, 2019 , ... MedTech Breakthrough , an ... and medical technology market, announced that it has selected Medacta International’s MySpine® MC ... in the 2019 MedTech Breakthrough Awards program. , Medacta® is ...
(Date:6/4/2019)... (PRWEB) , ... June 04, 2019 , ... ... manufacturing of orthopedic medical devices, today announced Q1-19 revenues of $31M, up 12% ... combined with successful roll-out of strategic investments & operational excellence initiatives worldwide. , ...
(Date:6/4/2019)... ... June 04, 2019 , ... Most preclinical EEG ... seizure risk signals, usually based on variations of amplitude, frequency or spike train ... diagnostic methodology due to the complexity and variability of the signal, and automation ...
Breaking Biology News(10 mins):
(Date:6/6/2019)... CYPRESS, Calif. (PRWEB) , ... June 05, 2019 , ... ... pharmaceutical, biotechnology and medical device industries, announced today that they will be receiving 3 ... in San Diego, CA. WCCT received 2 awards in the categories of overall Quality ...
(Date:5/31/2019)... DURHAM, N.C. (PRWEB) , ... May 30, 2019 ... ... Medicine is the first to demonstrate an efficient delivery system for the sustained ... kidney injuries. The platelet-rich plasma-based gel system was able to deliver CM into ...
(Date:5/14/2019)... ... May 13, 2019 , ... ... testing instruments for the Pharmaceutical, Biotechnology, Medical Device and Food Packaging Industries’ is ... redesigned website aims to improve LDA’s ability to communicate directly with the marketplace; ...
(Date:5/4/2019)... ... May 03, 2019 , ... Diopsys Inc, the world ... Negative Response vision test, a new full field electroretinography (ffERG) protocol designed ... 6.3 million Americans will have glaucoma, with black Americans having the highest prevalence ...
Breaking Biology Technology:
Cached News: